Andrew Hill

Research interests

Publications

• Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2407417

• Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

  Zurich Open Repository and Archive (University of Zurich) · 2022 · https://doi.org/10.5167/uzh-213514

• Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

  Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.06.008

• Characteristics of Early-Onset vs Late-Onset Colorectal Cancer

  JAMA Surgery · 2021 · https://doi.org/10.1001/jamasurg.2021.2380

• Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

  The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30700-9

• Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations: 2018

  World Journal of Surgery · 2018 · https://doi.org/10.1007/s00268-018-4844-y

• Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

  Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2017.76.9901

• Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30422-9

• Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709684

• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504030

• Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations

  World Journal of Surgery · 2012 · https://doi.org/10.1007/s00268-012-1772-0

• Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations

  Clinical Nutrition · 2012 · https://doi.org/10.1016/j.clnu.2012.08.013

• Implementation of ERAS and how to overcome the barriers

  International Journal of Surgery · 2008 · https://doi.org/10.1016/j.ijsu.2008.11.004

• Lymph Node Evaluation and Long-Term Survival in Stage II and Stage III Colon Cancer: A National Study

  Annals of Surgical Oncology · 2008 · https://doi.org/10.1245/s10434-008-0265-8

• Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

  Journal of Clinical Oncology · 1997 · 10.1200/jco.1997.15.1.261

Current projects

No projects listed.